MEG3 and neoplasm: Consistently, tumor weight in the mice of the Lv-sh-MEG3 + DDP treatment group was remarkably greater than that of the Lv-sh-NC + DDP treatment group (Fig. 6E), suggesting that MEG3 knockdown promoted tumor growth and inhibited DDP chemotherapy sensitivity in vivo.